A About
Anivance AI (久浪智醫) combines organ-on-chip systems, lab automation and multi-agent AI to model human biology (lung, liver, heart, kidney, tumor) and accelerate drug development without animal testing. Founded in Taiwan by Dr. Guan-Yu Chen; raised NT$72M in seed funding.
Focus Areas
Technology Focus
agents healthcare ai
Key People 1
- Guan-Yu Chen
Quick Stats
- Founded
- 2021
- Status
- private
- Type
- startup
Explore More
Similar Companies
Ranked by shared focus areas, technology, and location.
PathAI
Boston, United States
62%
1 shared category
1 shared AI type
Drug Discovery
Insitro
South San Francisco, United States
62%
1 shared category
1 shared AI type
Drug Discovery
Atomwise
San Francisco, United States
62%
1 shared category
1 shared AI type
Drug Discovery
InstaDeep
Tunis, Tunisia
62%
1 shared category
1 shared AI type
Drug Discovery